GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » ROE %

Qianhai Health Holdings (HKSE:00911) ROE % : 33.53% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Qianhai Health Holdings's annualized net income for the quarter that ended in Dec. 2023 was HK$118.8 Mil. Qianhai Health Holdings's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was HK$354.4 Mil. Therefore, Qianhai Health Holdings's annualized ROE % for the quarter that ended in Dec. 2023 was 33.53%.

The historical rank and industry rank for Qianhai Health Holdings's ROE % or its related term are showing as below:

HKSE:00911' s ROE % Range Over the Past 10 Years
Min: -93.27   Med: -0.13   Max: 30.85
Current: -13.8

During the past 11 years, Qianhai Health Holdings's highest ROE % was 30.85%. The lowest was -93.27%. And the median was -0.13%.

HKSE:00911's ROE % is ranked worse than
74.9% of 996 companies
in the Drug Manufacturers industry
Industry Median: 4.225 vs HKSE:00911: -13.80

Qianhai Health Holdings ROE % Historical Data

The historical data trend for Qianhai Health Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings ROE % Chart

Qianhai Health Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.12 -0.12 -0.13 -42.21 -12.84

Qianhai Health Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 5.76 -89.92 -58.91 33.53

Competitive Comparison of Qianhai Health Holdings's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianhai Health Holdings's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's ROE % falls into.



Qianhai Health Holdings ROE % Calculation

Qianhai Health Holdings's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-52.705/( (436.705+384.114)/ 2 )
=-52.705/410.4095
=-12.84 %

Qianhai Health Holdings's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=118.826/( (324.605+384.114)/ 2 )
=118.826/354.3595
=33.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Qianhai Health Holdings  (HKSE:00911) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=118.826/354.3595
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(118.826 / 1242.784)*(1242.784 / 447.795)*(447.795 / 354.3595)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.56 %*2.7753*1.2637
=ROA %*Equity Multiplier
=26.53 %*1.2637
=33.53 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=118.826/354.3595
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (118.826 / 118.826) * (118.826 / 122.056) * (122.056 / 1242.784) * (1242.784 / 447.795) * (447.795 / 354.3595)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.9735 * 9.82 % * 2.7753 * 1.2637
=33.53 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Qianhai Health Holdings ROE % Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings (HKSE:00911) Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Hou Chung Man 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Chong Siew Hoong 2202 Interest of your spouse
Lim Tzea 2101 Beneficial owner
Explorer Rosy Limited
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd 2106 Person having a security interest in shares

Qianhai Health Holdings (HKSE:00911) Headlines

No Headlines